Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors-Reference-Cited by-同舟云学术

Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors

Published:2007 Issue:3 Volume:109 Page:528-535
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Eggener Scott E.,Carver Brett S.,Loeb Stacy,Kondagunta G. Varuni,Bosl George J.,Sheinfeld Joel

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Testicular Germ-Cell Cancer

2. Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

3. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.

4. Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients

5. Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives;Current Oncology Reports;2024-03-02

2. Expertise Area 3.2: Testicular cancer;Rare and Complex Urology;2024

3. Resection of Residual Masses After Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumors in Adolescents and Adults;Journal of Clinical Oncology;2023-08-10

4. Retroperitoneal Lymph Node Dissection;A Guide to Management of Urological Cancers;2023

5. Structure of residual metastases in patients with advanced testicular non-seminomatous germ cell tumors and incomplete serological and radiological response to chemotherapy;Cancer Urology;2022-05-06